Brown Advisory Inc Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Brown Advisory Inc

$74.6 Billion
Q2 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$144.95 - $152.29 $2.77 Million - $2.91 Million	-19,124 Reduced 2.48%	752,048 $114 Million
Q2 2022 Nov 14, 2022	SELL	$83.14 - $145.99 $9.34 Million - $16.4 Million	-112,398 Reduced 12.72%	771,172 $112 Million
Q2 2022 Sep 13, 2022	SELL	$83.14 - $145.99 $72,996 - $128,179	-878 Reduced 0.12%	746,074 $109 Million
Q2 2022 Aug 02, 2022	SELL	$83.14 - $145.99 $8.9 Million - $15.6 Million	-107,019 Reduced 12.53%	746,952 $109 Million
Q1 2022 Nov 14, 2022	BUY	$110.08 - $142.92 $15.1 Million - $19.7 Million	137,496 Added 18.43%	883,570 $105 Million
Q1 2022 Sep 13, 2022	SELL	$110.08 - $142.92 $175,247 - $227,528	-1,592 Reduced 0.19%	853,971 $101 Million
Q1 2022 May 09, 2022	BUY	$110.08 - $142.92 $735,774 - $955,277	6,684 Added 0.79%	855,563 $102 Million
Q4 2021 Jan 27, 2022	SELL	$99.73 - $148.48 $18.4 Million - $27.4 Million	-184,323 Reduced 17.84%	848,879 $117 Million
Q3 2021 Nov 12, 2021	SELL	$98.85 - $138.91 $806,912 - $1.13 Million	-8,163 Reduced 0.78%	1,033,202 $144 Million
Q2 2021 Jul 29, 2021	BUY	$65.78 - $105.02 $3.4 Million - $5.43 Million	51,677 Added 5.22%	1,041,365 $101 Million
Q1 2021 May 14, 2021	BUY	$64.07 - $91.75 $6.5 Million - $9.3 Million	101,404 Added 11.42%	989,688 $67.6 Million
Q4 2020 Feb 12, 2021	BUY	$65.07 - $98.24 $1.88 Million - $2.84 Million	28,891 Added 3.36%	888,284 $76.1 Million
Q3 2020 Nov 16, 2020	BUY	$59.04 - $77.95 $671,520 - $886,603	11,374 Added 1.34%	859,393 $55.9 Million
Q2 2020 Aug 14, 2020	BUY	$29.01 - $74.23 $1.96 Million - $5.02 Million	67,578 Added 8.66%	848,019 $62 Million
Q1 2020 May 15, 2020	BUY	$27.51 - $57.29 $2 Million - $4.17 Million	72,757 Added 10.28%	780,441 $26.6 Million
Q4 2019 Feb 14, 2020	SELL	$40.86 - $57.65 $15.6 Million - $22 Million	-382,308 Reduced 35.07%	707,684 $38.5 Million
Q3 2019 Nov 14, 2019	BUY	$37.38 - $49.47 $3.06 Million - $4.05 Million	81,946 Added 8.13%	1,089,992 $45.5 Million
Q2 2019 Aug 12, 2019	BUY	$39.79 - $67.01 $15.2 Million - $25.5 Million	380,764 Added 60.7%	1,008,046 $44.1 Million
Q1 2019 May 15, 2019	BUY	$34.52 - $53.29 $6 Million - $9.27 Million	173,873 Added 38.35%	627,282 $32.3 Million
Q4 2018 Feb 13, 2019	BUY	$29.75 - $42.9 $13.5 Million - $19.5 Million	453,409 New	453,409 $16.8 Million

Others Institutions Holding BHVN

# of Institutions

Shares Held

785K

Call Options Held

Put Options Held

View Full List

About Biohaven Pharmaceutical Holding Co Ltd.

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $3.65B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

More about BHVN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Brown Advisory Inc, based on Form 13F filings with the SEC.

News

Stay updated on Brown Advisory Inc with notifications on news.

Account